We show its ability to bind the PSA antigen and the FcεRI, to induce effector cell degranulation when effectively cross-linked (but not in the presence of the natural soluble antigen), and when complexed to PSA to induce T-cell stimulation and anti-tumor activity in vivo. This evidence concerns the gene KLK3 and neoplasm.